It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

Viking Therapeutics ( VKTX -0.30%) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may ...

Viking celebrates the start of its 2025 European river season as its fleet embarks on their journey across the continent's ...

Viking (NYSE:VIK – Get Free Report) had its target price lowered by investment analysts at Morgan Stanley from $53.00 to ...

The Minnesota Vikings appear to be out on Aaron Rodgers, but they haven't completely closed the door on the future Hall of ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Viking Holdings shares dropped Tuesday as executives warned of macroeconomic "uncertainties" on the cruise operator's ...

Consumers across Europe furious over President Donald Trump’s policies are boycotting U.S. goods. Among the most passionate ...

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

With vice president of sales and national accounts Michele Saegesser departing Viking, the company has promoted Erik De La ...

Viking has launched its 2025 European river season, with its fleet of Viking Longships setting sail along Europe’s waterways, ...

Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...